Status:
TERMINATED
Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy
Lead Sponsor:
Agennix
Conditions:
Carcinoma, Non-small Cell Lung
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
PURPOSE: This trial is designed to compare the combination of the investigational oral cytotoxic drug, satraplatin, and radiation therapy for patients with locally advanced Non-Small Cell Lung Cancer ...
Eligibility Criteria
Inclusion
- Locally advanced or medically inoperable NSCLC (stage II or III)
- ECOG performance status score 0-2
- Adequate bone marrow, liver, and pulmonary functions
- Life expectancy \> three months.
Exclusion
- Prior malignancy
- Serious concurrent uncontrolled medical disorder.
- Uncontrolled or significant cardiovascular disease
- History of mastectomy
- Pregnant or breast-feeding patients are not eligible
- Prior radiotherapy to the primary tumor site or cytotoxic chemotherapy
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00093132
Start Date
August 1 2004
End Date
February 1 2009
Last Update
August 17 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southwestern Medical Center
Dallas, Texas, United States, 75390